跳至主要内容
临床试验/ACTRN12619001518156
ACTRN12619001518156尚未招募未知

itric Oxide on ExtraCorporeal Membrane Oxygenation – a randomised Trial in neonates and children (NECTAR trial).

The University of Queensland0 个研究点目标入组 50 人开始时间: 2019年11月4日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
Days 至 17 Years(—)
性别
All

入选标准

  • 1. All neonates and children < 18 years requiring ECMO for respiratory or cardiovascular dysfunction including extracorporeal cardiopulmonary resuscitation (eCPR)
  • 2. Ability to obtain prospective consent or consent to continue from parents/guardian.

排除标准

  • 1. Patients retrieved to PICU on ECMO who did not undergo randomisation during cannulation
  • 2. Pre-existing methaemoglobinemia (MetHb>3%)
  • 3. Anticipated inability to obtain parental consent (prospective consent or consent to continue)
  • 4. Patients managed on ventricular assist device (VAD) only without an oxygenator present in the ECMO circuit

研究者

相似试验

itric Oxide on ExtraCorporeal Membrane Oxygenation –... | 临床试验